Patients with EMT often have a poor quality of life compared to those who do not develop EMT.47 In our study, SSRP1 was identified to participate in the regulation of EMT in CRC, so SSRP1 may be a vital target for reversing drug resistant properties in CRC. This evidence concerns the gene SSRP1 and colorectal carcinoma.